More research needs to be done to understand how female hormones affect sleep, experts say. But sleep diaries, trackers and apps can be useful tools for those with problems.
Category: Washington Post
How you can repurpose your angst into growth, productivity and even happiness
In the book “Good Anxiety,” a neuroscientist explains the many ways we can learn to regulate such emotions.
Former surgeon resigns from National Academies panel on transplant reform
The retired transplant surgeon recently accepted a position with a consulting company
U.S. to buy hundreds of millions more doses of Pfizer vaccine to donate to the world
In June, the United States purchased 500 million doses of the vaccine to be distributed by Covax, the World Health Organization-backed initiative to share doses around the globe.
A doctor called coronavirus vaccines ‘fake.’ Now he sits on an Idaho regional health board
Cole’s elevation to a public health role is to critics an extreme example of GOP-driven resistance to not only mandates but basic medical guidance, as the pandemic overwhelms Idaho’s hospitals like never before.
California is seeing covid-19 cases drop. Has the state turned the tide on the delta variant?
Experts say the state’s embrace of vaccines, masks and other public health measures has helped it contain the highly transmissible delta.
She demanded a hospital treat her husband’s covid-19 with ivermectin. A judge said no.
A nurse sued for the right her husband the deworming drug that some people have used to treat or prevent covid-19 in recent months. A Louisville judge denied the request in a scathing ruling that called out people on the Internet who have promoted the …
Parenting a child under 12 in the age of delta: ‘It’s like a fire alarm every day’
Parenting a child under 12 can be maddening and scary during normal times, but the delta variant — and an increase in pediatric covid cases — has taken things to a new level.
FDA review remains neutral on boosters ahead of critical Friday vote even as Pfizer pushes additional shots
A highly-anticipated Food and Drug Administration review of evidence on whether a booster shot of the Pfizer-BioNTech coronavirus vaccine is widely necessary struck a noncommittal tone Wednesday.
At the besieged FDA, ‘it never stops!’ as decisions loom on boosters, pediatric shots and more
Internal conflicts over whether — and when — to approve boosters are part of a tumultuous season with few parallels for the federal agency.
